Background
==========

John Cunningham virus (JCV) constitutes a family of polyoma viruses, which contain small, circular and double-stranded DNA genomes. The early region is alternatively spliced to produce large *T antigen*and small *t antigen*\[[@B1]\]. T antigen, a large nuclear phosphoprotein for viral DNA replication, binds to viral replication region to promote the unwinding of double helix and recruitment of cell proteins that are required for DNA synthesis. The late region encodes the capsid structural protein VP1, VP2 and VP3 due to alternative splicing and the small regulatory protein known as agnoprotein \[[@B1],[@B2]\]. VP proteins are essential to assemble with viral DNA to form virons. Serological studies have indicated an asymptomatic JCV infection in about 90% of the adult population, but it may be activated under immunosuppressive conditions, leading to the lethal demyelinating disease, progressive multifocal leukoencephalopathy (PML) \[[@B1]-[@B5]\]. Evidences from transgenic and infectious animal models indicated that JCV could transform cells and cause various malignancies \[[@B6]-[@B9]\]. In recent years, links have been suggested between JCV and various types of human cancers, including colorectal, prostate and esophageal cancers, brain tumors, bronchopulmonary carcinoma and B cell lymphoma \[[@B1]-[@B9]\], pointing out its roles as oncovirus. However, no bibliometric investigation has been reported to guide the researchers and potential readers.

Investigators in some fields commonly predict that decision making for the following experiments, clinical practice and paper\'s submission should be based on the findings of scientific studies published in journals. Although scientific papers have provided useful and helpful information to the readers, it is a little difficult to learn about the history, status and future trend of some study field. The bibliometric method employs empiric data and quantitative analysis to trace the core production or citation, the content or quality of publications, and motivations of the researchers in the form of published literature so that it proves to be a valid and reliable way to map external and internal features of a scientific field \[[@B10]\]. A key assumption underpinning this method to catch insight into the flow of knowledge is that investigation papers represent knowledge produced by scientific research. Generally, academic productivity of individuals or groups is measured by counting the number of publications. The number of times that one work is cited is viewed as a measure of research impact. That is, the more frequently a paper is cited, the higher its impact or quality \[[@B10],[@B11]\]. Examination of bibliometric information shows the communication patterns of the investigation within the field and the patterns of influence among different work. Authors who publish earlier and experience frequent citations tend to accrue the number of citations over time as Matthew effect describes. For example, co-citation analysis (in which two papers are cited together in a paper) can indicate a strong conceptual relationship between the studies. On the other hand, PubMed indexes journal articles using MeSH terms, which constitute a thesaurus that embodies all the concepts appearing in the medical literature and are arranged in a hierarchical, tree-like structure by subject categories. Associated with MeSH is a list of corresponding subheadings to enhance the focus of MeSH searches. The combination of MeSH terms and subheadings can not only facilitate the sensitivity and specificity of search, but also indicate the research contents and the relationship between papers \[[@B12]-[@B14]\]. If the further co-occurrence cluster analysis of MeSH is applied in some field, the close link between subtrees of the field will be well established.

In the present study, production and citation of JCV research have been analyzed using such bibliometric methods as chronological, co-citation and co-occurrence analysis to explore the whole history, current status and frontier about JCV study.

Methods
=======

Data collection
---------------

The bibliographic data were collected in the database of the Institute for Scientific Information available on the web (<http://www.isiknowledge.com>, Sci-expanded) and National Library of Medicine on the web (<http://www.ncbi.nlm.nih.gov/sites/entrez>, Pubmed) until May 22, 2008. The tile, author, address, source, references or the US list of the papers were downloaded according to the retrieval strategy of \"JC virus OR John Cunningham virus OR JCV OR JC polyomavirus OR JC polyoma virus\" for Sci-expanded or Pubmed.

Highly-produced and -cited analysis
-----------------------------------

Using Foxpro 5.0, Microsoft Excel, Bibliographic Item Co-occurrence Mining System (BIOCOMS) provided by Cui Lei and Sci-expanded statistical system, we applied Sci-expanded data to determine the document types, core authors, highly-produced institutes and countries. The references were analyzed to clarify the distribution of highly-cited papers, authors and journals. The top MeSH/subheading words were collected from Pubmed and subjected to statistical analysis for highly-frequent ones.

Cluster analysis
----------------

After their identification, the top 34 most-cited articles were subjected to co-citation cluster analysis according to their co-citation times in one paper. The 48 highly-frequent MeSH/subheadings of all articles from Pubmed were studied using co-occurrence cluster analysis in term of their co-existence times in one paper. In any cluster analysis, the matrixes were built up according to co-citation or -occurrence times between the selected articles or words. Then, the related matrixes were developed using Ochiai index as previously described \[[@B15]-[@B18]\]. Finally, we employed the SPSS 10.0 software to perform the cluster analysis of these related matrixes.

Results
=======

Core countries, institutes, authors and journals
------------------------------------------------

Until May 22, 2008, 1785 articles about JCV were indexed in Sci-expanded with 62508 references and 1506(225 reviews) in Pubmed with 6435 major MeSH/subheading words. The literature about JCV was gradually rising from 3 articles in 1976 until 179 in 2006 as indicated in Figure [1](#F1){ref-type="fig"}. The average annual growth rate was 5.7 pieces in the period. According to document type, there were 1307 original articles (73.2%), 123 reviews (6.9%) and 209 meeting abstracts (11.7%) in all collected literature (Table [1](#T1){ref-type="table"}). In overall 21 countries listed, USA, Japan, Italy and Germany were in order the largest four producers about JCV despite 62 countries included (Table [2](#T2){ref-type="table"}). The overall 1245 institutes were mentioned to investigate JCV, among which Temple University of USA published 128 papers and ranked the top, followed by University of Tokyo, and National Institute of Neurological Disorder and Stroke subsequently. Fourteen of 21 (66.7%) core institutes come from USA with three core institutes in Italy (Table [3](#T3){ref-type="table"}). Such 33 authors as Khalili K, Yogo Y and etc produced more than 20 documents in spite of all 4856 authors involved. There were 9 highly-produced scientists from Temple University and 6 from University of Tokyo, Japan, and 4 from National Institute of Neurological Disorder and Stroke, USA respectively (Table [4](#T4){ref-type="table"}). As shown in Table [5](#T5){ref-type="table"}, Journal of Neurovirology, Journal of Virology, Virology, Journal of Medical Virology, Journal of General Virology and so forth published more than 15 papers and were considered as the core journals although there existed JCV papers in 395 journals. These source journals mainly include the field of Virology, Neurosciences, Clinical Neurology, Immunology, Pathology, Oncology and so on (Table [6](#T6){ref-type="table"}).

![**Temporal distribution of production about JCV investigation**.](1471-2334-9-28-1){#F1}

###### 

Document types of the scientific papers about JCV

  Num   Document type        Record count   Percentage(%)
  ----- -------------------- -------------- ---------------
  1     Original article     1307           73.2
  2     Meeting abstract     209            11.7
  3     Review               123            6.9
  4     Note                 63             3.5
  5     Letter               40             2.2
  6     Editorial material   31             1.7
  7     Correction           4              0.20
  8     Book review          3              0.17
  9     Discussion           2              0.11

###### 

The territory distribution of the scientific papers about JCV

  Num   Country       Record count   Percentage(%)
  ----- ------------- -------------- ---------------
  1     USA           968            54.2
  2     Japan         190            10.6
  3     Italy         173            9.7
  4     Germany       158            8.8
  5     UK            88             5.0
  6     France        72             4.0
  7     Spain         48             2.7
  8     Switzerland   44             2.5
  9     Canada        37             2.1
  10    Sweden        36             2.0
  11    Taiwan        24             1.3
  12    Norway        22             1.2
  13    China         15             0.8
  14    Australia     14             0.8
  15    Poland        13             0.7
  16    Belgium       12             0.7
  17    Brazil        12             0.7
  18    South Korea   12             0.7
  19    Lithuania     11             0.6
  20    Finland       10             0.6
  21    Netherlands   10             0.6

###### 

The core institutes to investigate the JCV

  Num   Institution name                                                            Country   Record count   Percentage(%)
  ----- --------------------------------------------------------------------------- --------- -------------- ---------------
  1     Temple University                                                           USA       128            7.2
  2     University of Tokyo                                                         Japan     86             4.8
  3     National Institute of Neurological and Communication Disorders and Stroke   USA       79             4.4
  4     Harvard University                                                          USA       61             3.4
  5     Hokkaido University                                                         Japan     59             3.3
  6     National Institute of Neurological Disorder and Stroke                      USA       56             3.1
  7     Pennsylvania State University                                               USA       56             3.1
  8     Thomas Jefferson University                                                 USA       47             2.6
  9     University of Milan                                                         Italy     40             2.2
  10    University of Wisconsin                                                     USA       39             2.2
  11    Brown University                                                            USA       38             2.1
  12    Johns Hopkins University                                                    USA       36             2.0
  13    National Cancer Institute                                                   USA       32             1.8
  14    University of California san Diego                                          USA       31             1.7
  15    University of Wurzburg                                                      Germany   29             1.6
  16    University of Pittsburgh                                                    USA       28             1.6
  17    IRCCS                                                                       Italy     25             1.4
  18    Baylor College of Medicine                                                  USA       24             1.3
  19    University of Hamburg                                                       Germany   24             1.3
  20    National Institute of Health                                                USA       23             1.3
  21    University of Ferrara                                                       Italy     20             1.1

###### 

The core authors for JCV investigation

  Num   Core author        Institutes                                                     Record count   Percentage(%)
  ----- ------------------ -------------------------------------------------------------- -------------- ---------------
  1     Khalili K          Temple University, USA                                         174            9.8
  2     Yogo Y             University of Tokyo, Japan                                     75             4.2
  3     Major EO           National Institute of Neurological Disorders and Stroke, USA   74             4.2
  4     Stoner GL          National Institute of Neurological Disorders and Stroke, USA   70             3.9
  5     Del Valle L        Temple University, USA                                         62             3.5
  6     Kitamura T         University of Tokyo, Japan                                     59             3.3
  7     Nagashima K        Hokkaido University, Japan                                     57             3.2
  8     Frisque RJ         Pennsylvania State University, USA                             48             2.7
  9     Ryschkewitsch CF   National Institute of Neurological Disorders and Stroke, USA   45             2.5
  10    Koralnik IJ        Harvard Medical School, USA                                    43             2.4
  11    Gordon J           Temple University, USA                                         42             2.4
  12    Sugimoto C         University of Tokyo, Japan                                     41             2.3
  13    Atwood WJ          Brown University, USA                                          40             2.2
  14    Walker DL          University of Wisconsin Medical School, USA                    39             2.2
  15    Zheng HY           University of Tokyo, Japan                                     37             2.1
  16    Ferrante P         University of Milan, Italy                                     33             1.9
  17    Sawa H             Hokkaido University, Japan                                     32             1.8
  18    Agostini HT        National Institute of Neurological Disorders and Stroke, USA   28             1.6
  19    Boland CR          Baylor University Medical Center, USA                          27             1.5
  20    Takasaka T         University of Tokyo, Japan                                     26             1.5
  21    White MK           Temple University, USA                                         26             1.5
  22    Croul S            Temple University, USA                                         25             1.4
  23    Safak M            Temple University, USA                                         25             1.4
  24    Wegner M           Universität Hamburg, Germany                                   25             1.4
  25    Amini S            Temple University, USA                                         24             1.3
  26    Padgett BL         University of Wisconsin Medical School, USA                    23             1.3
  27    Reiss K            Temple University, USA                                         22             1.2
  28    Tanaka S           Hokkaido University, Japan                                     22             1.2
  29    Berger JR          Temple University, USA                                         21             1.2
  30    Butel JS           Baylor University Medical Center, USA                          21             1.2
  31    Dorries K          Universität Würzburg, Germany                                  21             1.2
  32    Shah KV            Johns Hopkins Bloomberg School of Public Health, USA           21             1.2
  33    Ikegaya H          University of Tokyo, Japan                                     20             1.1

###### 

Core journals of JCV investigation

  Num   Source title                                                                      Record count   Percentage(%)
  ----- --------------------------------------------------------------------------------- -------------- ---------------
  1     Journal of Neurovirology                                                          167            9.4
  2     Journal of Virology                                                               128            7.2
  3     Virology                                                                          69             3.9
  4     Journal of Medical Virology                                                       51             2.9
  5     Journal of General Virology                                                       44             2.5
  6     Annals of Neurology                                                               36             2.0
  7     Journal of Infectious Diseases                                                    35             2.0
  8     Journal of Clinical Micrology                                                     31             1.7
  9     Journal of Neuropathology and Experimental Neurology                              31             1.7
  10    AIDS                                                                              29             1.6
  11    Journal of Biological Chemistry                                                   29             1.6
  12    Neurology                                                                         29             1.6
  13    Oncogene                                                                          25             1.4
  14    Proceedings of The National Academy of Sciences of The United States of America   25             1.4
  15    Journal of Virological Methods                                                    24             1.3
  16    Transplantation                                                                   23             1.3
  17    Gastroenterology                                                                  21             1.2
  18    Anthropological Science                                                           20             1.1
  19    International Journal of Cancer                                                   20             1.1
  20    Polyomaviruses and Human Diseases                                                 19             1.1
  21    Archives of Virology                                                              17             1.0
  22    Clinical Infectious Diseases                                                      16             0.9
  23    American Journal of Transplantation                                               15             0.8
  24    New England Journal of Medicine                                                   15             0.8

###### 

Subject categories for JCV investigation

  Num   Subject category                       Record count   Percentage (%)
  ----- -------------------------------------- -------------- ----------------
  1     Virology                               601            33.7
  2     Neurosciences                          329            18.4
  3     Clinical Neurology                     238            13.3
  4     Immunology                             154            8.6
  5     Pathology                              154            8.6
  6     Oncology                               144            8.1
  7     Biochemistry & Molecular Biology       142            8.0
  8     Infectious Diseases                    128            7.2
  9     Biotechnology & Applied Microbiology   103            5.8
  10    Cell Biology                           85             4.8
  11    Microbiology                           80             4.5
  12    Transplantation                        80             4.5
  13    Surgery                                73             4.1
  14    Genetics & Heredity                    61             3.4
  15    Medicine, Research & Experimental      60             3.4
  16    Medicine, General & Internal           58             3.3
  17    Evolutionary Biology                   40             2.2
  18    Hematology                             35             2.0
  19    Urology & Nephrology                   34             1.9
  20    Pediatrics                             33             1.9
  21    Biochemical Research Methods           32             1.8
  22    Gastroenterology & Hepatology          31             1.7
  23    Multidisciplinary Sciences             31             1.7

Highly-cited authors, journals and papers
-----------------------------------------

The papers of 10 highly-cited authors (totally 1577 producers) like Padgett BL and Berger JR were cited for more than 400 times, among whom 8 persons come from USA (Table [7](#T7){ref-type="table"}). The 10 highly-cited journals (totally 3584 journals) were selected due to more than 1179 citation times, including 3 for Virology and 4 for comprehensive journals (Table [8](#T8){ref-type="table"}). Journal of Virology and Journal of Neurovirology respectively ranked to the first two among 404 cited journals (Table [9](#T9){ref-type="table"}). The highly-cited papers were chronologically analyzed and grouped into two stages: (1) 1971--1984: discovery and isolation of JCV in PML disease and (2) 1985-present: clarification of JCV genomic DNA sequence and its correlation with diseases (Table [9](#T9){ref-type="table"}).

###### 

The highly-cited authors for JCV papers

  Num   Authors       Institute                                                      CT    CP(%)
  ----- ------------- -------------------------------------------------------------- ----- -------
  1     Padgett BL    University of Wisconsin Medical School, USA                    958   1.53
  2     Berger JR     University of Kentucky, USA                                    761   2.75
  3     Agostini HT   National Institute of Neurological Disorders and Stroke, USA   649   3.79
  4     Frisque RJ    Pennsylvania State University, USA                             630   4.80
  5     Major EO      National Institute of Neurological Disorders and Stroke, USA   604   5.77
  6     Walker DL     Tulane University, USA                                         495   6.56
  7     Arthur RR     Johns Hopkins University, USA                                  430   7.25
  8     Dorries K     University of Wurzburg, Germany                                419   7.92
  9     Yogo Y        University of Tokyo, Japan                                     415   8.58
  10    Shah KV       Johns Hopkins University, USA                                  400   9.23

CT, cited time; CP, cumulative percentage

###### 

The highly-cited journals for JCV papers

  Num   Journal                                                                           CT     CP(%)
  ----- --------------------------------------------------------------------------------- ------ -------
  1     Journal of Virology                                                               5871   9.43
  2     Virology                                                                          2498   13.44
  3     Proceedings of The National Academy of Sciences of The United States of America   2313   17.16
  4     Journal of Infectious Diseases                                                    2230   20.74
  5     New England Journal of Medicine                                                   1655   23.40
  6     Journal of Neurovirology                                                          1274   25.45
  7     Science                                                                           1230   27.42
  8     Cell                                                                              1227   29.39
  9     Journal of Clinical Microbiology                                                  1201   31.32
  10    Annals of Neurology                                                               1179   33.22

CT, cited time; CP, cumulative percentage

###### 

The highly-cited articles for the JCV investigation

  N    Authors         Year   Title                                                                                                                                                           Source               V     P      CT    CP
  ---- --------------- ------ --------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------- ----- ------ ----- ------
  1    Padgett BL      1971   Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.                                                              Lancet               1     1257   366   0.59
  2    Frisque RJ      1984   Human polyomavirus JC virus genome.                                                                                                                             J Virol              51    458    360   1.16
  3    Major EO        1992   Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain                 Clin Microbiol Rev   5     49     285   1.62
  4    Padgett BL      1973   Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy                                   J Infect Dis         127   467    219   1.97
  5    Chesters PM     1983   Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.                                                          J Infect Dis         147   676    215   2.31
  6    Berger JR       1987   Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.   Ann Intern Med       107   78     197   2.63
  7    Astrom KE       1958   Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin\'s disease                         Brain                81    93     179   2.91
  8    Yogo Y          1990   Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals.                                                                 J Virol              64    3139   172   3.19
  9    Gardner SD      1971   New human papovavirus (B.K.) isolated from urine after renal transplantation                                                                                    Lancet               1     1253   165   3.45
  10   Tornatore C     1992   Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy                                   Ann Neurol           31    454    146   3.69
  11   Kitamura T      1990   High incidence of urinary JC virus excretion in nonimmunosuppressed older patients.                                                                             J Infect Dis         161   1128   136   3.90
  12   Houff SA        1988   Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.           New Engl J Med       318   301    135   4.12
  13   Berger JR       1995   Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare                                                                     J Neurovirol         1     5      134   4.33
  14   Arthur RR       1989   Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction.                                                                  J Clin Microbiol     27    1174   132   4.55
  15   Walker DL       1973   Human papovavirus (JC): induction of brain tumors in hamsters                                                                                                   Science              181   674    128   4.75
  16   Loeber G        1988   DNA rearrangements in organ-specific variants of polyomavirus JC strain GS                                                                                      J Virol              62    1730   126   4.95
  17   White FA        1992   JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy                                            J Virol              66    5726   117   5.14
  18   Agostini HT     1996   Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.                                                                     J Clin Microbiol     34    159    114   5.32
  19   Bergsagel DJ    1992   DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood                                                         New Engl J Med       326   988    108   5.49
  20   Brooks BR       1984   Progressive multifocal leukoencephalopathy                                                                                                                      Neurol Clin          2     299    108   5.67
  21   Markowitz RB    1993   Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.                                                   J Infect Dis         167   13     108   5.84
  22   Kenney S        1984   Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.                                                     Science              226   1337   107   6.01
  23   London WT       1978   Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus).                                                                                    Science              201   1246   106   6.18
  24   Coleman DV      1980   A prospective study of human polyomavirus infection in pregnancy                                                                                                J Infect Dis         142   1      105   6.35
  25   Dorries K       1994   Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals.                                                    Virology             198   59     105   6.52
  26   Gardner SD      1984   Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients                                                            J Clin Pathol        37    578    104   6.68
  27   Flaegstad T     1991   Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction                                            Virology             180   553    102   6.85
  28   Hogan TF        1980   Human polyomavirus infections with JC virus and BK virus in renal transplant patients                                                                           Ann Intern Med       92    373    101   7.01
  29   Martin JD       1985   Differences in regulatory sequences of naturally occurring JC virus variants                                                                                    J Virol              53    306    97    7.16
  30   Monaco MCG      1996   JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency.                       J Virol              70    7004   96    7.32
  31   Richardson EP   1961   Progressive multifocal leukoencephalopathy                                                                                                                      New Engl J Med       265   815    95    7.47
  32   Randhawa PS     1999   Human polyoma virus-associated interstitial nephritis in the allograft kidney.                                                                                  Transplantation      67    103    92    7.62
  33   Frisque RJ      1992   The molecular biology of JC virus, causative agent of progressive multifocal leukoenchephalpathy                                                                Mol Neurovirology          25     92    7.76
  34   Padgett BL      1977   JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships    Infect Immun         15    656    90    7.91

V, volume; P, page; CT, cited times; CP, cumulative percentage

Co-citation analysis of highly-cited articles
---------------------------------------------

In the overall references about JCV, most highly-cited articles were published before 1999 with more than 90 citation times and came from major journals, such as Journal of Infectious Disease, Journal of Virology, Science, New England Journal of Medicine and so forth. As shown in Figure [2](#F2){ref-type="fig"}, these top highly-cited articles were divided into 5 aspects by co-citation analysis: (1) The correlation between JC virus and tumors; (2) Causal correlation of JCV with PML: pathogenesis and molecular biology; (3) Polyoma virus infection and its related diseases in renal-allograft recipients; (4) Detection of JCV antibody, gene and encoding protein; (5) Genetics and molecular biology of JCV.

![**Co-citation cluster analysis of highly-cited references**.](1471-2334-9-28-2){#F2}

Co-occurrence analysis of highly-frequent MeSH/subheading words
---------------------------------------------------------------

The 48 highly-frequent MeSH/subheading words generally existed for more than 25 times in the papers about JCV (Table [10](#T10){ref-type="table"}). Among them, 17 words (35.4%) belonged to the C02 subcategory of MeSH (Viral Disease) and 15 (31.3%) to B04 subcategory (Viruses). These MeSH/subheadings were classified into five groups: (1) JCV and virus infectious diseases; (2) JCV pathogenicity and pathological appearance of PML; (3) JCV isolation and detection; (4) Immunology of JCV and PML; (5) JCV genetics and tumors(Figure [3](#F3){ref-type="fig"}).

![**Co-occurrence cluster analysis of the highly-frequent MeSH/subheading words**.](1471-2334-9-28-3){#F3}

###### 

The highly-frequent MeSH/subheading words

  Num   MeSH/subheading words                                       Subcategory number        Times   CP
  ----- ----------------------------------------------------------- ------------------------- ------- -------
  1     JC Virus/Genetics                                           B04.280.640.615.400       289     4.49
  2     JC Virus/Isolation and Purification                         B04.280.640.615.400       216     7.84
  3     Leukoencephalopathy, Progressive Multifocal/Virology        C02.182.500.300.500       115     9.63
  4     Leukoencephalopathy, Progressive Multifocal/Diagnosis       C02.182.500.300.500       86      10.96
  5     JC Virus/Physiology                                         B04.280.640.615.400       84      12.27
  6     JC Virus/Immunology                                         B04.280.640.615.400       73      13.40
  7     Polyomavirus/Genetics                                       B04.280.640.615           69      14.47
  8     Leukoencephalopathy, Progressive Multifocal/Pathology       C02.182.500.300.500       68      15.53
  9     BK Virus/Isolation and Purification                         B04.280.640.615.100       68      16.58
  10    DNA, Viral/Analysis                                         D13.444.308.568           64      17.57
  11    Leukoencephalopathy, Progressive Multifocal/Drug Therapy    C02.182.500.300.500       58      18.48
  12    JC Virus/Pathogenicity                                      B04.280.640.615.400       56      19.34
  13    Tumor Virus Infections/Virology                             C02.928                   54      20.18
  14    Polyomavirus Infections/Virology                            C02.256.721               51      20.98
  15    Leukoencephalopathy, Progressive Multifocal/Etiology        C02.182.500.300.500       50      21.75
  16    BK Virus/Genetics                                           B04.280.640.615.100       50      22.53
  17    Leukoencephalopathy, Progressive Multifocal/Microbiology    C02.182.500.300.500       47      23.26
  18    Leukoencephalopathy, Progressive Multifocal/Complications   C02.182.500.300.500       45      23.96
  19    JC Virus                                                    B04.280.640.615.400       45      24.65
  20    Polyomavirus/Isolation and Purification                     B04.280.640.615           42      25.31
  21    Acquired Immunodeficiency Syndrome/Complications            C02.782.815.616.400.040   39      25.91
  22    Polyomaviridae                                              B04.280.640               38      26.50
  23    DNA, Viral/Genetics                                         D13.444.308.568           37      27.08
  24    HIV Infections/Complications                                C02.782.815.616.400       36      27.64
  25    Gene Expression Regulation, Viral                           G05.315.385               35      28.18
  26    Polymerase Chain Reaction/Methods                           E05.393.620.500           34      28.71
  27    Polyomavirus/Immunology                                     B04.280.640.615           34      29.23
  28    Leukoencephalopathy, Progressive Multifocal/Immunology      C02.182.500.300.500       34      29.76
  29    Tumor Virus Infections/Diagnosis                            C02.928                   33      30.27
  30    Tumor Virus Infections/Complications                        C02.928                   33      30.79
  31    Brain/Virology                                              A08.186.211               33      31.30
  32    Capsid Proteins                                             D12.776.964.970.600.550   33      31.81
  33    Brain/Pathology                                             A08.186.211               31      32.29
  34    Promoter Regions (Genetics)                                 G06.184.603.080.689.675   31      32.77
  35    Genes, Viral                                                G14.330.605               30      33.24
  36    JC Virus/Metabolism                                         B04.280.640.615.400       30      33.71
  37    Virus Replication                                           G04.185.515.880.941       29      34.16
  38    Polyomavirus Infections/Complications                       C02.256.721               28      34.59
  39    DNA, Viral/Cerebrospinal Fluid                              D13.444.308.568           28      35.03
  40    Neuroglia/Virology                                          A08.637                   28      35.46
  41    Brain Neoplasms/Virology                                    C04.588.614.250.195       27      35.88
  42    AIDS-Related Opportunistic Infections/Drug Therapy          C01.539.597.050           27      36.30
  43    Tumor Virus Infections/Microbiology                         C02.928                   27      36.72
  44    Simian virus 40/Isolation and Purification                  B04.280.640.615.700       27      37.14
  45    Brain/Microbiology                                          A08.186.211               25      37.53
  46    Kidney Transplantation                                      E02.870.500               25      37.91
  47    Polyomavirus Infections/Diagnosis                           C02.256.721               25      38.30
  48    BK Virus/Immunology                                         B04.280.640.615.100       25      38.69

CP, cumulative percentage

Discussion
==========

A systematic view of JCV papers to discern the distinct set of core researchers, institutional affiliations and corresponding countries helps us to gain a deeper understanding of approaches to JCV. As shown in our bibliometric analysis, the document type of JCV was original articles (1307/1785) and many data (209/1785) had been communicated in meeting activities. The review part occupies 6.9% (123/1785). The results indicated that JCV research was very active and interesting many investigators, and some scientists had begun to summary the achievement of JCV. Among 33 core authors, 19 persons come from Temple University, University of Tokyo, and National Institute of Neurological Disorder and Stroke, which ranked the top in the highly-produced institutes. Additionally, 14 (66.7%) core institutes of USA also focused on the investigation of JCV and USA was the first top producer of JCV papers until now. JVC was discovered in 1971 by American Padgett and named after the two initials of a patient with progressive multifocal leukoencephalopathy (PML). It was suggested that the JCV investigation originated from USA, which consequently became the top source information for JCV. It is rational and helpful for the scientists to tack the core authors and institutes to grasp the frontier of this field, open new projects and submit their distinguished work.

The list of top-cited articles about JCV identified the authors, articles and topics that reflected history and development of this specialty. Among highly-cited authors, Padgett is the discoverer for JCV in PML and published the first article in Lancet. The paper has been cited for 366 times and ranks the top in the highly-cited ones. His outstanding was also due to another article in Journal of Infectious disease, which described the detection of the antibody against JCV in PML. Therefore, it is explanatory for Padgett BL to be the most highly cited. These top-cited articles produced valuable information for readers, but also tell us some historical achievement in some field. According to these highly-cited papers, the research about JCV was chronologically separated into beginning and developing stages including discovery and isolation of JCV in PML disease, and clarification of JCV genomic DNA sequence and its relationship with diseases by polymerase chain reaction (PCR) respectively.

Most of highly-cited journals almost come from Virology, Neurology, and comprehensive journals, indicating JCV paper mainly absorbs frontier knowledge from these fields. Oncogene, Journal of Biological Chemistry, and International Journal of Cancer also become the highly-cited journal (data not shown), indicating the attempts of JCV study to combine with Molecular Biology and Oncology. This data also demonstrate the close link of JCV with these specialties. In the overall references of JCV papers, most highly-cited articles were published in Proceeding of National Academy and Science, USA and New England Journal of Medicine, indicating that these famous-brand journals highlight the investigation of JCV and emphasized the scientific achievement of JCV. Therefore, investigators of JCV not only read the journals of Virology, but also emphasized the novel findings of JCV published in other journals with high impact factor.

Methodologically, the cluster techniques include text segmentation, summary extraction, feature selection, term association, cluster generation, topic identification, and information mapping \[[@B19]\]. Clustering algorithms prominently used in co-citation analysis has proved very useful in revealing research streams in some discipline \[[@B20]-[@B23]\]. Here, we carried out empirical co-citation analysis to map the network of highly-cited papers about JCV. Our data indicated that these top highly-cited articles were grouped into such 4 aspects as the correlation between JC virus and tumors, causal correlation of JCV with PML, polyoma virus infection and its related diseases in renal-allograft recipients, detection of JCV antibody, oncogene and its encoding protein, and genetics and molecular biology of JCV. These findings might not only enrich the knowledge of students and specialists about the development\'s history of JCV research, but also open new bursts of scientific investigation.

Co-occurrence has been considered as carriers of meaning across different domains in studies of science. Based on this principle, we performed co-occurrence cluster analysis using Pubmed MeSH/subheading words to construct a new tie between two words depending on the co-existing frequencies \[[@B24]\]. Consequently, most of the top highly-frequent MeSH/subheading words are mainly classified into C02 subcategory of MeSH (Viral Disease) and B04 subcategory (Viruses). The analytic data showed that the contents of published papers about JCV included JCV isolation and detection, as well as JCV and virus infectious diseases like PML or tumors. It was suggested that JCV investigation centered on its isolation, its pathogenicity of PML and its genetics at early time. Recently, the causal relationship between JCV and tumors has been emphasized by the scientists. It was demonstrated that JCV investigation like isolation and detection mainly aimed to clarify the molecular mechanism of its relevant diseases including PML and tumors.

As well known, JCV infection experiences two outcomes as other viruses. In un-permissive condition, JCV infection initiates binding to the JCV-sensitive cell surface and JCV capsids undergo endocytosis and are transported to the nucleus where the viral DNA is uncoated and the early and late region begins to be transcripted. Subsequently, JCV genomic DNA is assembled with caspid protein to undergo the lytic viral release, finally to cause demyelinating disease, PML. Under permissive infection, viral DNA can replicate, resulting in lytic infection with viral amplification and non-permissive cells don\'t allow the viral replication, leading to an abortive infection or cell transformation \[[@B6]-[@B9]\]. The evidence provided enough reasons for the following data: (1) The core and highly-cited journals mainly contained the field of virology, neurology and oncology; (2) The highly-cited articles and highly-frequent MeSH/subheading also mentioned the research contents of JCV, PML and tumors.

Recently, the further clarification of JCV genetics promoted the scientists to detect its genomic existence in tumors or make the transgenic mice to study the oncogenic role of JCV. Our group had examined the JCV targeting T antigen using nested-PCR, real-time PCR, in situ PCR, in situ hybridization, and immunohistochemistry \[[@B6]-[@B9]\]. It was found that positive rate and copies of JCV were higher in gastric, lung and tongue carcinomas than corresponding normal tissues, indicating its oncogenic role in epithelial carcinogenesis. Furthermore, JCV T antigen can serve as helicase, and polymerase, orchestrate the assembly and function of cellular proteins, disrupt the signal pathways of p53, Rb and Wnt signaling pathway, and should be considered as a viral oncogene \[[@B2]-[@B4]\]. Therefore, we are establishing a transgenic model of gastric neoplasia induced by JCV T antigen, which will help to verify the oncogenic role of JCV in gastric carcinoma and provide a novel tool to investigate gastric carcinomas. It was hypothesized that application of JCV T antigen in tumor transgenic animal model would be a novel and hot project in the future.

Conclusion
==========

In this study, we successfully performed the scientometric analysis of JCV literature. Our data indicated that JCV mainly centered on PML and tumors. The bibliometric study assists researchers to know the history and frontier of JCV investigation, guide them to open new projects and submit the distinguished work. These cluster methods employed in this investigation can clarify the history, status and development in the field of JCV.
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